/
SiriusPoint is a global specialty underwriter of insurance and reinsurance, headquartered in Bermuda. Our common shares are listed on the New York Stock Exchange ( NYSE ) under the symbol SPNT.
$24.90
+$0.09 (+0.36%)
EOD Jul 17, 2026
Net margin is thin at 14.33%. This may reflect rising credit costs, rate compression, or operational inefficiency.
Revenue grew 23.1% YoY.
Financial stocks carry unique risks (credit cycles, regulatory changes, interest rate sensitivity) that aren't captured by standard quality metrics.
6.3x earnings. Below the sector average, the market may be pricing in credit losses or regulatory headwinds, or there's genuine value here.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
$3.25B
▲ +23.1% YoY
Net Income (TTM)
$500M
▲ +129.9% YoY
Net Margin
15.37%
P/E
6.3x
Balance Sheet
Total Assets
$12.48B
Equity
$2.30B
Total Debt
$703M
Cash & Equiv.
$889M
5Y CAGR: +29.2%
Continue Research
At a P/E of 6.3, SiriusPoint (SPNT)'s valuation is best read against its own history, its peers, and the growth its price implies. A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, SiriusPoint scores 99/100 on Intrinsiqq's quality scorecard (a high-quality business on these measures), weighing growth, margins, returns on capital, share count, and balance-sheet strength. All figures are computed from SEC filings; read the full . This is analysis, not investment advice.
SiriusPoint scores 99 out of 100 on Intrinsiqq's quality score, a weighted blend of 8 metrics each scored 0 to 100, which makes it a high-quality business on these measures. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from SEC filings, not opinion. Because valuation only means something relative to quality, the full metric-by-metric breakdown is on the quality scorecard.
That depends on valuation and quality together, not either alone. you should weigh SPNT's valuation and scores 99/100 on quality (high-quality). A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from SEC filings, not investment advice.